{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:16:47Z","timestamp":1791400607391,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":2443,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jviscsurg.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T23:30:24Z","timestamp":1414020624000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer"],"prefix":"10.1016","volume":"151","author":[{"given":"N.","family":"Bakrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Classe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1999.17.3.767","article-title":"Natural history of stage\u00a0IV epithelial ovarian cancer","volume":"17","author":"Bonnefoi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0015","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2007.03.012","article-title":"The management of recurrent ovarian cancer","volume":"34","author":"Bukowski","year":"2007","journal-title":"Semin Oncol"},{"issue":"Suppl.\u00a010","key":"10.1016\/j.jviscsurg.2014.07.005_bib0025","doi-asserted-by":"crossref","first-page":"x69","DOI":"10.1093\/annonc\/mdt475","article-title":"New developments in the treatment of ovarian cancer \u2013\u00a0future perspectives","volume":"24","author":"Lopez","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2014.07.005_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0091270009360980","article-title":"Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure","volume":"51","author":"Cotte","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02656739709023545","article-title":"Reduction of cellular cisplatin resistance by hyperthermia \u2013\u00a0a review","volume":"13","author":"Hettinga","year":"1997","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0050","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0055","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0060","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0070","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.jviscsurg.2014.07.005_bib0075","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase\u00a0III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0085","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage\u00a0III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1055-3207(18)30039-5","article-title":"Intraperitoneal chemohyperthermia: rationale, technique, indications, and results","volume":"10","author":"Elias","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0105","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C","article-title":"Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery","volume":"79","author":"Fujimoto","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2003.06.139","article-title":"Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase\u00a0II study","volume":"21","author":"Glehen","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","article-title":"Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00268-004-7461-x","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer","volume":"28","author":"Zanon","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/030089160108700302","article-title":"Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase\u00a0II clinical study","volume":"87","author":"Deraco","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2006.10.051","article-title":"Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma","volume":"105","author":"Helm","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7819-2-21","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer","volume":"2","author":"Piso","year":"2004","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","article-title":"Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan","volume":"32","author":"Raspagliesi","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","article-title":"Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer","volume":"94","author":"Rufian","year":"2006","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.jviscsurg.2014.07.005_bib0160","article-title":"Results of a phase\u00a0I dose escalation trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer","volume":"49","author":"Gouy","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.21732","article-title":"Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: a pilot study of 31\u00a0patients","volume":"103","author":"Frenel","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","article-title":"Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer","volume":"102","author":"Roviello","year":"2010","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2014.07.005_bib0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","article-title":"Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase\u00a0II prospective multicentre trial. CHIPOVAC study","volume":"36","author":"Pomel","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0185","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejso.2009.03.004","article-title":"Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer \u2013\u00a012-year single center experience","volume":"35","author":"Pavlov","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Di Giorgio","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jviscsurg.2014.07.005_bib0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jso.21448","article-title":"Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer","volume":"101","author":"Kim","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0200","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566\u00a0patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0205","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290\u00a0patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0215","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","article-title":"Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase\u00a0II prospective multicentre trial. CHIPOVAC study","volume":"36","author":"Pomel","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0220","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care","volume":"61","author":"Launay-Vacher","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejso.2013.11.019","article-title":"Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216\u00a0patients","volume":"40","author":"Passot","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1684\/bdc.2010.1165","article-title":"Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis","volume":"97","author":"Lim","year":"2010","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0235","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/annonc\/mdt237","article-title":"Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe fran\u00e7aise d\u2019oncologie gynecologique, SFOG)","volume":"24","author":"Querleu","year":"2013","journal-title":"Ann Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.jviscsurg.2014.07.005_bib0240","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(11)70154-X","article-title":"Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer","volume":"47","author":"Ledermann","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0245","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage\u00a0IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0250","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry","volume":"20","author":"Helm","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0265","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2013.06.022","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?","volume":"39","author":"Gonzalez Bayon","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0270","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0275","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdn591","article-title":"The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer","volume":"20","author":"Oksefjell","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0285","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246\u00a0patients","volume":"19","author":"Bakrin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0290","first-page":"74","article-title":"The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study","volume":"16","author":"Spiliotis","year":"2011","journal-title":"J BUON"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0295","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12094-009-0438-3","article-title":"The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer","volume":"11","author":"Munoz-Casares","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jviscsurg.2014.07.005_bib0300","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two-year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788614000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788614000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:30:38Z","timestamp":1761809438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878788614000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1878788614000988"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2014.07.005","relation":{},"ISSN":["1878-7886"],"issn-type":[{"value":"1878-7886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}